Sun, Mar 1, 2015, 12:37 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Regeneron Pharmaceuticals, Inc. Message Board

  • faosto faosto Nov 16, 2012 2:17 PM Flag

    Another way to look at REGN

    Most of the M&A talk surrounding REGN centers on REGN being bought out by SNY or other large pharma, but I think REGN may soon become a buyer itself of smaller companies. It will soon have a $20 billion market cap, easily capable of swallowing small promising companies with a phase 3 or even approved drug for $2-3 billion a clip in all-stock transactions. On the cholesterol front, it looks like REGN727 is more effective than Amgen's, but less than Pfizer's. However, REGN will be first to market and should capture a significant chunk of that market.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
413.84-6.03(-1.44%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.